Legislators
Bills
Statements
Lobbying
Travel
- Bills
- H.R.597
H.R.597: Pandemic Treatment Access and Affordability Act of 2021
About This Bill
- This bill was introduced in the 117th Congress
- This bill is primarily about health
- Introduced Jan. 28, 2021
- Latest Major Action March 22, 2021
- See the one similar bills introduced in other congresses.
Bill Sponsor
Bill Cosponsors
26 (All Democrats)
Bill Version
- Introduced in House - Jan. 28, 2021
Bill Summary
Pandemic Treatment Access and Affordability Act of 2021 This bill imposes licensing and price restrictions on federally supported drugs and other medicines intended to address COVID-19 (i.e., coronavirus disease 2019) or other public health emergencies. With respect to a COVID-19 drug patent developed using certain types of federal support, any license granted by the federal government shall be open and nonexclusive. Similarly, a licensee or...
(Source: Library of Congress)
What Lawmakers Are Saying About This Bill
Bill Actions
Date | Description |
---|---|
March 22, 2021 |
Referred to the Subcommittee on Courts, Intellectual Property, and the Internet.
|
Feb. 2, 2021 |
Referred to the Subcommittee on Health.
|
Jan. 28, 2021 |
Referred to the Committee on Energy and Commerce, and in addition to the Committees on the Judiciary, Science, Space, and Technology, and Armed Services, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
|
Jan. 28, 2021 |
Introduced in the House by Jan Schakowsky (D-Ill.) |